dpp-4 inhibitor and glp-1 receptor agonist combination not recommended guideline Clinical Use of Inhibitors Development of a treatment selection

Berberine (BBR) exhibits significant anti-diabetic effects by enhancing insulin sensitivity, promoting glycolysis, and inhibiting gluconeogenesis

Supports overall daily wellness

Tirzepatide displayed an unprecedented glucose and body weight lowering potential, presenting also with the ability to increase insulin sensitivity, reduce systolic blood pressure and inflammation and ameliorate dyslipidemia, particularly by reducing triglycerides levels

The aim of this narrative review is to critically assess the renoprotective effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in managing albuminuria among patients with type 2 diabetes mellitus within the framework of personalized ...

Ships from USA, EU, UK, CA, AU warehouses

If you are taking medications or have a medical condition, speak with your provider before use